MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2025 International Congress

    Hyperbaric Oxygen Therapy for Parkinson’s disease via modulation of gut microbiota

    V. Vedam-Mai, J. Long, N. Nair, D. Fuller, K. Deegan, S. Rana, G. Iglesias, I. Gonzalez, U. Dissanayake, V. Mai (Gainesville, USA)

    Objective: To investigate the effect of hyperbaric oxygen therapy (HBOT) on gut microbiota in a preclinical model of PD. Background: Humans have coevolved with complex…
  • 2025 International Congress

    Advancements in Microbiome Research: Total Microbial Load, Differential Absolute Abundance, and Correlations with Immune Transcriptomics

    B. Palushaj, M. Chakraborty, I. Porter, G. Reynolds, E. Brooks, Z. He, A. Bhatt, K. Poston (Palo Alto, USA)

    Objective: Quantify total microbial load in the gut microbiome of people with Parkinson’s disease (PD) and compare the absolute abundance of bacterial taxa between PD…
  • 2025 International Congress

    Gastrointestinal Dysfunction and Levodopa Therapeutic Response in Parkinson’s Disease: A Brazilian Cross-sectional Study

    N. Dos Santos, G. de Vasconcelos, G. Piñeiro, F. Brito, J. Oliveira, S. Baran, J. Costa, E. Muricy, R. Kauark (Salvador, Brazil)

    Objective: To investigate the relation between constipation and the onset time of levodopa therapeutic effect in Parkinson's disease (PD). Background: Levodopa therapeutic response depends on…
  • 2025 International Congress

    Novel Insights into the Association Between Parkinson’s Disease and Constipation: Role of SHMT2 as a Promising Biomarker

    JH. Su, EX. Tao (Shenzhen, China)

    Objective: This study aims to  analyze the shared molecular pathways between Parkinson’s disease (PD) and constipation through integrative bioinformatics methodologies and further validate candidate biomarkers…
  • 2025 International Congress

    Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

    S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

    Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
  • 2025 International Congress

    Impact of Constipation on Motor and Non-Motor Symptoms in G2019s Lrrk2 Parkinson’s Disease A Retrospective Study

    A. Agrebaoui, R. Zouari, A. Mousli, R. Amouri, A. Rachdi, F. Nabli, Z. Saied, S. Ben Sassi (Tunis, Tunisia)

    Objective: This study aimed to investigate the association between constipation and the severity of motor and non-motor symptoms in PD patients with the G2019S LRRK2…
  • 2025 International Congress

    The Role of Diet in the Relationship Between Hyposmia and Constipation in Patients with Parkinson’s Disease

    J. Yu, S. Schaffner, J. Lam, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To assess the relationship between diet in the relationship between non-motor symptoms in Parkinson’s disease (PD). Background: While the etiology of PD is not…
  • 2024 International Congress

    Constipation in Early-Onset Parkinson’s Disease: frequency, time of onset and association with mortality

    C. Piat, A. Mullan, K. Ghoniem, P. Turcano, J. Bower, E. Benarroch, R. Savica (Rochester, USA)

    Objective: We aimed to determine the frequency, time of onset and mortality association of constipation in patients with Early-Onset Parkinson’s Disease (EOPD). Background: Constipation is…
  • 2024 International Congress

    Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease

    K. Julio, A. Vakhtin, H. Lin, A. Birg, N. Hoffman, S. Nitschke, N. Shaff, E. Erhardt, A. Mayer, D. Sugar, G. Suarez Cedeno, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether patients with PD exhibit 1) a bloom in sulfate-reducing bacteria based on the detection of hydrogen-sulfide (H2S) during lactulose breath testing…
  • 2024 International Congress

    Evaluation of Effectiveness of Medical Nutrition Therapy Services for Individuals with Parkinson’s Disease: A Quality Improvement Initiative

    S. Mandali, K. Lyons, K. Lee, K. Au, A. Lee, R. Pahwa (KansasCity, USA)

    Objective: To assess the type of dietetic consultation services used in a Parkinson Disease Center of Excellence (PDCE) for individuals with Parkinson’s disease (PD). 2.To…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley